The health and medical microalgae market is estimated to capture a valuation of US$ 729 million in 2023 and is projected to reach US$ 1,337 million by 2033. The market is estimated to secure a CAGR of 6% from 2023 to 2033.
| Attribute | Details |
|---|---|
| Market CAGR (2023 to 2033) | 6% |
| Market Valuation (2023) | US$ 729 million |
| Market Valuation (2033) | US$ 1,337 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Due to changing lifestyle patterns and hectic schedules, there has been a significant rise in the reported cases of lifestyle-based ailments in recent years. Consumers are taking preventative measures to mitigate the effects of such conditions.
As a result, the consumption of joint and bone health supplements is increasing. These supplements contain additives controlling blood pressure, including vitamins and amino acids. The intake of dietary supplements is rapidly rising, which benefits the microalgae market because it is an important ingredient in dietary supplements.
Healthcare costs have more than doubled in recent years, owing to increased spending on research and development activities by key healthcare and medical industry players. Increasing healthcare costs influence consumers to choose health supplements, which provide health benefits, including pain relief, minimizing cartilage breakdown, and improving overall health.
According to Research America, medical and health research expenditure in the USA increased from US$ 114,386 million to US$ 121,825 million in 2019 compared to the previous year. As healthcare costs continue to rise, consumers prefer dietary supplements to maintain a healthy lifestyle. The growing popularity of health supplements benefits the microalgae market as it is widely used in health supplements.
Principal Consultant
As awareness of animal welfare rises, the number of people who are vegan or vegetarian is growing by the day. Several organizations, such as NGOs, are attempting to minimize animal slaughter. Generation Z and millennials are actively involved in these non-governmental organizations. Furthermore, these non-governmental organizations (NGOs) organize various programs to promote veganism.
Microalgae are high in nutrient content, including carotene, astaxanthin, docosahexaenoic acid, EPA, phycobilin pigments, and other carotenoids. Its use in health supplements is increasing because it is vegan and highly nutritious. The growing vegan population is boosting microalgae growth in the health and medical sector.
Microalgae products have been approved for use in the pharmaceutical and nutraceutical industries. Microalgae is a highly nutritious and rich source of various vitamins, which is why, after regulatory approval, the demand for microalgae is increasing from the pharmaceutical and nutraceutical sectors.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
As per Future Market Insights (FMI), the global market grew at a steady CAGR of 3% between 2018 and 2022. The market captured a valuation of US$ 624.2 million in 2018 and US$ 647.50 million in 2022.
Strong growth is on the card for the global pharmaceutical industry, especially with investment in drug development amplifying consistently. It also points towards a favourable demand outlook for microalgae in the health and medical sector.
Driven by a growing emphasis on natural ingredients in the healthcare sector, microalgae application is estimated to surge because they are a rich source of nutrients such as β-carotene, astaxanthin, docosahexaenoic acid, EPA, phycobilin pigments, and other carotenoids.
Astaxanthin has been studied to show an effective response against atherosclerosis. Consumers are seeking clean-label products. Consequently, microalgae consumption in the pharmaceutical industry is set to increase in the foreseeable future.
Microalgae sales have gained momentum in European countries and throughout the United States. This provides a lucrative opportunity for manufacturers to advertise products with trending health claims.
Consumers, particularly millennials, prefer transparency and clean label formulations. Microalgae producers for health and medical sector application are likely to capitalize on changing consumer preferences to carve a niche amid increasing competition.
Spirulina contains anti-inflammatory, antioxidant, and immune-stimulating compounds such as phycocyanin, polysaccharides, and phenolic. Furthermore, spirulina processing products are used in nutraceuticals, dietary supplements, pharmaceutics, and medicine.
Thus, spirulina is estimated to account for US$ 251.8 million in 2023, with a CAGR of 4.1% during the forecast period. Spiruline is estimated to secure a share of 21.40% in the global market by 2033.
Freshwater sources of microalgae are estimated to account for nearly 80% of the market share in 2021, which is expected to grow at a CAGR of 5.3% over the forecast period to reach US$ 860.1 Million in 2031.
Easy availability of raw materials, extensive artificial cultivation operations and cost benefits are key factors aiding growth.
The nutraceuticals and dietary supplements segment accounted for a maximum share of nearly 84% in 2021, which is also expected to witness a significant growth rate of CAGR of 5.3% over the forecast period.
Microalgae are gaining interest as a source of nutraceuticals and dietary supplements because they can produce a variety of biological molecules and compounds, which are beneficial to animal and human health development.
| Countries | Current Market Share 2023 |
|---|---|
| United States | 24.3% |
| Germany | 9.9% |
| Japan | 2.0% |
| Australia | 1.0% |
| Countries | Current Market CAGR 2023 |
|---|---|
| China | 6.7% |
| India | 8.9% |
| United Kingdom | 7.9% |
According to FMI, North America dominates the global demand for microalgae in the health and medical sector during the forecast period. According to recent research, the United States is expected to account for 24.3% of the global market during the forecast period.
Healthcare consumes well over 10% of the GDP in various developed countries. It is not surprising, given that the healthcare industry is a significant employer in the country. The United States spends far more on healthcare than the rest. Thus, increased spending on healthcare here is creating better opportunities for microalgae in the health and medical sector.
Rising demand for microalgae-based health and medical products in Germany captures a significant growth in the global market. According to a recent report, the demand in Germany is expected to be worth US$ 29.3 million in 2023.
Manufacturers need an extensive network of suppliers and distributors of their products to accomplish this. These manufacturers are also expanding their distribution networks. However, this is primarily done by the industry's leading manufacturers. Germany is anticipated to register a share of 9.9% in the global market by 2033.
Brazil is one of the major developing countries in the world. By 2033, it is expected to account for more than 44% of the demand for microalgae in Latin America's health and medical sector.
Brazil's economy is widely regarded as one of the fast-growing economies in Latin America. The country has seen positive growth in many aspects of its economy, including consumer spending, investment, and government spending. The healthcare market is the most successful in the country, accounting for approximately 9.7% of the total GDP, creating a conducive environment for growth.
According to FMI's analysis, China is estimated to hold nearly 39% of the Asia Pacific value share in 2023. Carotenoids are becoming more popular in China owing to the large animal feed industry and increased demand for health supplements. China is securing a CAGR of 6.7% in the global market by 2033.
Furthermore, the highly established pharmaceuticals industry, which uses carotenoids and related product types to meet market demand, contributes to microalgae growth in the health and medical sector.
Older adults make up a large proportion of the population in China, and they are the most frequent users of predictive and preventive medicine. These health issues, including vision loss, are frequently associated with vitamin deficiency. So, according to FMI, as the demand for carotenoids rises globally, it is estimated to positively impact the growth of the microalgae market in China.
Japan accounted for more than 32% of the market share, with a total share of 2.0% in the global market. In Japan, consumers do not get enough antioxidants because they do not eat enough vegetables, fish and fruits.
Microalgae is a powerful antioxidant that works to supplement dietary formulations. It allows manufacturers to differentiate their products and give their antioxidant products a competitive advantage. The popularity of dietary supplements with antioxidant claims is growing Japan's healthcare and medical microalgae market.
Manufacturers of microalgae-based products can benefit from increasing the frequency of product launches to better reach consumers and meet the growing demand for microalgae products in the health and medical sector. New market participants can formulate diversified microalgae formats and incorporate them into nutraceutical products to attract a larger consumer base.
Prominent Players in the Global Market are:
Recent Developments in the Global Market are:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Species Type, Source, End Use Application, Region |
| Key Companies Profiled | DIC Corporation; Koninkliijke DSM NV; Roquette Frères; Sun chlorella; Cellana LLC; Fuji Chemical Industries Co., Ltd.; Corbion (TerraVia Holdings); Yunnan Green-A-Bio-engineering Co Ltd; Buggypower; Cyanotech Corporation; BASF SE; Parry Nutraceuticals; Beijing Gingko Group; KDI Ingredients; Algatec (Lusoamoreiras); Others |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is expected to secure a valuation of US$ 1,337 million by 2033.
The market is estimated to be valued at US$ 729 million in 2023.
The market is expected to expand at a CAGR of 6% through 2033.
Roquette Frères, Sun chlorella, and Cellana LLC are key players in the market.
The market exhibited a CAGR of 3% from 2018 to 2022.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (MT) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (MT) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Species Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Species Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Species Type, 2023 to 2033 5.3.1. Spirulina 5.3.2. Chlorella 5.3.3. Dunaliella 5.3.4. Aphanizomenon 5.3.5. Haematococcus 5.3.6. Crypthecodinium 5.3.7. Schizochytrium 5.3.8. Euglena 5.3.9. Nannochloropsis 5.3.10. Nostoc 5.3.11. Phaedactylum 5.3.12. Others 5.4. Y-o-Y Growth Trend Analysis By Species Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Species Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Source 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Source, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Source, 2023 to 2033 6.3.1. Marine Water 6.3.2. Fresh Water 6.4. Y-o-Y Growth Trend Analysis By Source, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Source, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By End Use Application, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By End Use Application, 2023 to 2033 7.3.1. Nutraceuticals and Dietary Supplements 7.3.2. Pharmaceuticals 7.4. Y-o-Y Growth Trend Analysis By End Use Application, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End Use Application, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Species Type 9.2.3. By Source 9.2.4. By End Use Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Species Type 9.3.3. By Source 9.3.4. By End Use Application 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Species Type 10.2.3. By Source 10.2.4. By End Use Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Species Type 10.3.3. By Source 10.3.4. By End Use Application 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Species Type 11.2.3. By Source 11.2.4. By End Use Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Species Type 11.3.3. By Source 11.3.4. By End Use Application 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Singapore 12.2.1.5. Thailand 12.2.1.6. Indonesia 12.2.1.7. Australia 12.2.1.8. New Zealand 12.2.1.9. Rest of Asia Pacific 12.2.2. By Species Type 12.2.3. By Source 12.2.4. By End Use Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Species Type 12.3.3. By Source 12.3.4. By End Use Application 12.4. Key Takeaways 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Species Type 13.2.3. By Source 13.2.4. By End Use Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Species Type 13.3.3. By Source 13.3.4. By End Use Application 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Species Type 14.1.2.2. By Source 14.1.2.3. By End Use Application 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Species Type 14.2.2.2. By Source 14.2.2.3. By End Use Application 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Species Type 14.3.2.2. By Source 14.3.2.3. By End Use Application 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Species Type 14.4.2.2. By Source 14.4.2.3. By End Use Application 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Species Type 14.5.2.2. By Source 14.5.2.3. By End Use Application 14.6. United Kingdom 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Species Type 14.6.2.2. By Source 14.6.2.3. By End Use Application 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Species Type 14.7.2.2. By Source 14.7.2.3. By End Use Application 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Species Type 14.8.2.2. By Source 14.8.2.3. By End Use Application 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Species Type 14.9.2.2. By Source 14.9.2.3. By End Use Application 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Species Type 14.10.2.2. By Source 14.10.2.3. By End Use Application 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Species Type 14.11.2.2. By Source 14.11.2.3. By End Use Application 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Species Type 14.12.2.2. By Source 14.12.2.3. By End Use Application 14.13. Singapore 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Species Type 14.13.2.2. By Source 14.13.2.3. By End Use Application 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Species Type 14.14.2.2. By Source 14.14.2.3. By End Use Application 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2022 14.15.2.1. By Species Type 14.15.2.2. By Source 14.15.2.3. By End Use Application 14.16. Australia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2022 14.16.2.1. By Species Type 14.16.2.2. By Source 14.16.2.3. By End Use Application 14.17. New Zealand 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2022 14.17.2.1. By Species Type 14.17.2.2. By Source 14.17.2.3. By End Use Application 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2022 14.18.2.1. By Species Type 14.18.2.2. By Source 14.18.2.3. By End Use Application 14.19. South Africa 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2022 14.19.2.1. By Species Type 14.19.2.2. By Source 14.19.2.3. By End Use Application 14.20. Israel 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2022 14.20.2.1. By Species Type 14.20.2.2. By Source 14.20.2.3. By End Use Application 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Species Type 15.3.3. By Source 15.3.4. By End Use Application 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. DIC Corporation 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Koninkliijke DSM NV 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Roquette Frères 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Sun chlorella 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Cellana LLC 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Fuji Chemical Industries Co., Ltd. 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Corbion (TerraVia Holdings) 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Yunnan Green-A-Bio-engineering Co Ltd 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Buggypower 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Cyanotech Corporation 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. BASF SE 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 16.1.12. Parry Nutraceuticals 16.1.12.1. Overview 16.1.12.2. Product Portfolio 16.1.12.3. Profitability by Market Segments 16.1.12.4. Sales Footprint 16.1.12.5. Strategy Overview 16.1.12.5.1. Marketing Strategy 16.1.12.5.2. Product Strategy 16.1.12.5.3. Channel Strategy 16.1.13. Beijing Gingko Group 16.1.13.1. Overview 16.1.13.2. Product Portfolio 16.1.13.3. Profitability by Market Segments 16.1.13.4. Sales Footprint 16.1.13.5. Strategy Overview 16.1.13.5.1. Marketing Strategy 16.1.13.5.2. Product Strategy 16.1.13.5.3. Channel Strategy 16.1.14. KDI Ingredients 16.1.14.1. Overview 16.1.14.2. Product Portfolio 16.1.14.3. Profitability by Market Segments 16.1.14.4. Sales Footprint 16.1.14.5. Strategy Overview 16.1.14.5.1. Marketing Strategy 16.1.14.5.2. Product Strategy 16.1.14.5.3. Channel Strategy 16.1.15. Algatec 16.1.15.1. Overview 16.1.15.2. Product Portfolio 16.1.15.3. Profitability by Market Segments 16.1.15.4. Sales Footprint 16.1.15.5. Strategy Overview 16.1.15.5.1. Marketing Strategy 16.1.15.5.2. Product Strategy 16.1.15.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Food and Beverage Insights
View Reports
Health and Medical Microalgae Market
